Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.84 USD | -9.33% | -26.38% | 0.00% |
Business Summary
Number of employees: 61
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Bladder-sparing Therapeutic
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +6.81% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +6.81% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Arthur Kuan
CEO | Chief Executive Officer | 34 | 17-11-29 |
Ambaw Bellete
PSD | President | 54 | 23-06-30 |
Vijay Kasturi
CTO | Chief Tech/Sci/R&D Officer | 57 | 23-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Graf
BRD | Director/Board Member | 52 | Nov. 19 |
Leonard Post
BRD | Director/Board Member | 72 | 18-10-21 |
Victor Tong
BRD | Director/Board Member | 41 | 23-06-30 |
James Mulé
BRD | Director/Board Member | 72 | 18-10-21 |
Arthur Kuan
CEO | Chief Executive Officer | 34 | 17-11-29 |
Hong Fang Song
BRD | Director/Board Member | 59 | 15-10-31 |
Brian Liu
BRD | Director/Board Member | 36 | 22-08-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 66,640,150 | 61,939,325 ( 92.95 %) | 0 | 92.95 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 1.9B | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- CGON Stock
- Company CG Oncology, Inc.